Founded in New Zealand, Argenta’s talented and committed employees are dedicated to delivering excellence in animal health to customers around the world. With research and/or GMP manufacturing operations in Germany, New Zealand, Spain, the United Kingdom, and the United States of America, Argenta holds a unique position as the only combined global contract research organisation (CRO) and contract development and manufacturing organisation (CDMO) specialising in animal health.
Argenta operates from Molecule to Market in partnership with customers of all sizes from all corners of the world, supporting their research and development, clinical research, regulatory, scale-up and manufacturing needs along the veterinary product development journey.
The day-to-day ethos that drives Argenta forward is a mission focused on global partnerships, a Molecule to Market approach, and innovation. At the core of the business and the organisation is collaboration – among the global employee base and with their customers.
Argenta proudly partners with a vast range of global customers. Our services and facilities scale to meet the requirements of the largest multinationals, whilst, at the other end of the spectrum, offering start-ups and small companies capabilities and solutions that help bring their ideas to fruition.
For more information, please visit www.argentaglobal.com.